Urofollitropin clinical trials
Also written Bravelle and fostimon.
How each study uses Urofollitropin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 18 Sept 1986 · FERTINEX · NDA 019415 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 9
Ferring Pharmaceuticals (3) · IVI Madrid (2) · University of California, San Francisco (1) · IBSA Institut Biochimique SA (1) · Clinique Ovo (1) · University of Stellenbosch (1) · St. Olavs Hospital (1) · Instituto de Investigacion Sanitaria La Fe (1)
Often tested with
Tested in the same studies.
Follitropin alfa (2) · Menotropins (2) · Follitropin beta (1)
Studies
Open first, then newest update. How each study uses Urofollitropin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 14
- Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized TrialCompletedPhase 4University of California, San FranciscoNCT00854373Written as Bravelle(follicle stimulating hormone)How we know
- FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)CompletedPhase 4IBSA Institut Biochimique SANCT01969201Written as UrofollitrophinHow we know
- Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility TreatmentTerminatedNot applicableSt. Olavs HospitalNCT01882166Written as fostimonHow we know
- Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)Status unknownPhase 4Instituto BernabeuNCT02625519Written as Urinary follicle-stimulating hormoneHow we know
- Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe OligozoospermiaTerminatedPhase 3Instituto de Investigacion Sanitaria La FeNCT02605070Written as BravelleHow we know
- Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese FemalesCompletedPhase 3Ferring PharmaceuticalsNCT01923194Written as Highly Purified UrofollitropinHow we know
- Biosimilar Versus Urinary GonadotropinsStatus unknownPhase 4IVI MadridNCT02503605Written as Urinary FSHHow we know
- Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) ProgramCompletedPhase 3Ferring PharmaceuticalsNCT01922193Written as Highly Purified UrofollitropinHow we know
- Gonadotropin Type in Ovarian StimulationCompletedPhase 4IVI MadridNCT02437032Written as Urinary FSHHow we know
- Menopur Mixed ProtocolCompletedPhase 4Ferring PharmaceuticalsNCT01417195Written as BravelleHow we know
- Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization CycleCompletedPhase 3Clinique OvoNCT00971152Written as urofollitropin for injectionHow we know
- Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome (PCOS)Status unknownPhase 2Genesis Center for Fertility & Human Pre-Implantation GeneticsNCT01337531Written as Gonal-F, FostimonHow we know
- Pregnancy/Implantation Rates Using a Day 3 Score Versus Graduated Embryo Score Plus a Biochemical Marker (sHLA-G)CompletedNot applicableUniversity of StellenboschNCT00680238Written as Human derived FSHHow we know
- Efficacy of Urinary Follicle-Stimulating Hormone (FSH) Among Poor RespondersStatus unknownNot applicableGerman Hospital, IstanbulNCT00677573Written as FostimonHow we know
Given beside what is tested · 1 — Urofollitropin is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Urofollitropin
- Single Dose FSH-GEX™ in Healthy VolunteersCompletedPhase 1Glycotope GmbHNCT01354886Written as BravelleHow we know
- Multiple Dose FSH-GEX(TM) in Healthy VolunteersCompletedPhase 1Glycotope GmbHNCT01477073Written as urinary FSHHow we know
- SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile WomenCompletedPhase 3Merck KGaA, Darmstadt, GermanyNCT01185782Written as Purified pituitary gonadotropin (Fertinorm-P®)How we know
Codes
What other systems call Urofollitropin · ClinicalTrials.gg INT008865
- UNII (FDA) W9BB98U6HPUROFOLLITROPINOne source FDA
- RxNorm 134404One source FDA
- NCI Thesaurus C80805UrofollitropinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | W9BB98U6HP | UROFOLLITROPIN | One source FDA |
| RxNorm | 134404 | — | One source FDA |
| NCI Thesaurus | C80805 | Urofollitropin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.